ASK120067 potently suppresses B-cell or T-cell malignancies in vitro and in vivo by inhibiting BTK and ITK

Overview of attention for article published in Frontiers in Pharmacology, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 4 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 8,335 followers.

ASK120067 potently suppresses B-cell or T-cell malignancies in vitro and in vivo by inhibiting BTK and ITK #lymphoma #lymsm https://t.co/Fc87lJKYci

02 Jan 2023

Reply Repost Favourite

ASK120067 potently suppresses B-cell or T-cell malignancies <em>in vitro</em> and <em>in vivo</em> by inhibiting BTK and ITK #lymphoma #lymsm https://t.co/J1mW58Vk49

02 Jan 2023

Reply Repost Favourite

New Research: ASK120067 potently suppresses B-cell or T-cell malignancies in vitro and in vivo by inhibiting BTK and ITK https://t.co/xCxHvCcI0H #pharmacology

15 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.